O'Brien Greene & Co’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,400
Closed -$220K 140
2021
Q3
$220K Sell
3,400
-2,000
-37% -$139K 0.08% 126
2021
Q2
$435K Sell
5,400
-7,000
-56% -$533K 0.16% 94
2021
Q1
$843K Sell
12,400
-1,000
-7% -$78.6K 0.33% 60
2020
Q4
$934K Buy
13,400
+500
+4% +$31.1K 0.38% 58
2020
Q3
$663K Hold
12,900
0.32% 63
2020
Q2
$756K Hold
12,900
0.4% 54
2020
Q1
$653K Hold
12,900
0.43% 54
2019
Q4
$956K Buy
+12,900
New +$805K 0.49% 50
2019
Q3
Sell
-3,400
Closed -$222K 111
2019
Q2
$222K Hold
3,400
0.12% 102
2019
Q1
$252K Hold
3,400
0.13% 96
2018
Q4
$203K Buy
+3,400
New +$274K 0.12% 102

Other funds holding HQY

O'Brien Greene & Co's HQY Position: Q4 2021 in Review

O'Brien Greene & Co sold out of HealthEquity (HQY) in Q4 2021, closing a stake of 3,400 shares — an estimated $220K sold.

O'Brien Greene & Co first reported a position in HQY in Q4 2018 and held it in 11 quarters. The position peaked at $956K in Q4 2019. 282 funds tracked by Wall St. Rank hold HQY as of Q4 2021.

  • O'Brien Greene & Co reported no remaining HealthEquity position as of Q4 2021 after selling out during the quarter.
  • O'Brien Greene & Co sold 3,400 HealthEquity shares in Q4 2021, an estimated $220K.
  • O'Brien Greene & Co first reported a position in HealthEquity in Q4 2018 and held it in 11 quarters.
  • O'Brien Greene & Co's HealthEquity position peaked at $956K in Q4 2019.
  • 282 funds tracked by Wall St. Rank held HealthEquity as of Q4 2021.

Based on O'Brien Greene & Co's 13F filing for Q4 2021, filed 8 Feb 2022.